Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity? episode artwork

EPISODE · May 1, 2025 · 40 MIN

Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?

from Citeline Podcasts · host Norstella

Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Alan Minsk of Arnall Golden Gregory, as well as Naya Therapeutics CEO Daniel Teper

Episode metadata supplied by the publisher feed · Published May 1, 2025

Embed this episode

NOW PLAYING

Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?

0:00 40:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 40 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on May 1, 2025.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!